Compare MCRB & SMJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCRB | SMJF |
|---|---|---|
| Founded | 2010 | 1988 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 123.8M |
| IPO Year | 2015 | 2025 |
| Metric | MCRB | SMJF |
|---|---|---|
| Price | $15.04 | $5.60 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | 43.7K | ★ 605.8K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.62 | 0.03 |
| Revenue | $351,000.00 | ★ $12,533,617.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $24.47 | $183.43 |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $6.53 | $4.25 |
| 52 Week High | $29.98 | $7.00 |
| Indicator | MCRB | SMJF |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 57.71 |
| Support Level | $14.41 | $5.06 |
| Resistance Level | $16.12 | $5.70 |
| Average True Range (ATR) | 0.83 | 0.30 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 44.28 | 75.96 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.